Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
1
0
0
0
Cyclo Therapeutics, Inc. - Warrant Share · US23254X1101 · CYTHW (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Cyclo Therapeutics, Inc. - Warrant
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 40,96 %
Shares Float 11,51 M
Shares Outstanding 28,11 M
Company Profile for Cyclo Therapeutics, Inc. - Warrant Share
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.
Company Data
Name Cyclo Therapeutics, Inc. - Warrant
Company Cyclo Therapeutics, Inc.
Symbol CYTHW
Website
http://www.cyclotherapeutics.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN US23254X1101
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO N. Scott Fine
Country United States of America
Currency USD
Employees 0,0 T
Address 6714 NW 16th Street, Gainesville
IPO Date 2020-12-18
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | CYTHW |
More Shares
Investors who hold Cyclo Therapeutics, Inc. - Warrant also have the following shares in their portfolio:
